Comparative analysis of IgM sub-variants in salmonid fish and identification of a residue in mu 3 which is essential for MAb4C10 reactivity

In rainbow trout (Onchorhynchus mykiss) it has been shown that high affinity IgM antibodies havea higher degree of disulfide polymerization and a longer half life time. In the present study, distinct IgMsub-variants related to ancestral tetraploidy in salmonidfish were analyzed to reveal possible charac-teristic differences between these. A monoclonal antibody (MAb4C10) which distinguishes between IgM-A and IgM-B in Atlantic salmon (Salmo salar) and brown trout (Salmo trutta) was further characterized. Itwas shown that substitution of a proline located in the loop between the B and C beta strands of the thirdconstant domain (m3) of salmonmA eliminated MAb4C10 reactivity. Accordingly, the reverse substitutionin salmonmB restored MAb4C10 reactivity. Molecular cloning ofmcDNA from arctic char (Salvelinusalpinus) revealed two sub-variants (mA-1 andmA-2), i.e. a similar situation as in Atlantic salmon andbrown trout. However, arctic char IgM eluted in one peak by anion exchange chromatography, in contrastto salmon and brown trout IgM that are eluted in two peaks. The only characteristic residue of salmonand brown troutmB is an additional cysteine in the C-terminal part ofm4. Most likely, this cysteine isinvolved in inter-chain disulfide bonding and influences the elution profiles of IgM-A and IgM-B on anionexchange chromatography. Neither of themsub-variants in arctic char have the additional cysteine, andchar IgM, as well as salmon and brown trout IgM-A, showed a lower degree of inter-chain disulfidebonding than IgM-B when subjected to denaturation and gel electrophoresis under non-reducingconditions. Hybrids of char/salmon expressedmA-1,mA-2,mA andmB, indicating that there are twoparalogous Ig heavy chain gene complexes in the haploid genome of char, like in Atlantic salmon. Acomparison of salmonidmsequences is presented, including representatives ofSalmoninae(trout, salmonand char),Thymallinae(grayling) andCoregoninae(whitefish)submittedVersio

Prediction of novel drug targets and vaccine candidates against human lice (insecta), acari (Arachnida), and their associated pathogens

The emergence of drug-resistant lice, acari, and their associated pathogens (APs) is associated with economic losses; thus, it is essential to find new appropriate therapeutic approaches. In the present study, a subtractive proteomics approach was used to predict suitable therapeutics against these vectors and their infectious agents. We found 9701 proteins in the lice (Pediculus humanus var. corporis) and acari (Ixodes scapularis, Leptotrombidium deliense), and 4822 proteins in the proteomes of their APs (Babesia microti, Borreliella mayonii, Borrelia miyamotoi, Borrelia recurrentis, Rickettsia prowazekii, Orientia tsutsugamushi str. Boryong) that were non-homologous to host proteins. Among these non-homologous proteins, 365 proteins of lice and acari, and 630 proteins of APs, were predicted as essential proteins. Twelve unique essential proteins were predicted to be involved in four unique metabolic pathways of lice and acari, and 103 unique proteins were found to be involved in 75 unique metabolic pathways of APs. The sub cellular localization analysis of 115 unique essential proteins of lice and acari and their APs revealed that 61 proteins were cytoplasmic, 42 as membrane-bound proteins and 12 proteins with multiple localization. The druggability analysis of the identified 73 cytoplasmic and multiple localization essential proteins revealed 22 druggable targets and 51 novel drug targets that participate in unique pathways of lice and acari and their APs. Further, the predicted 42 membrane bound proteins could be potential vaccine candidates. Screening of useful inhibitors against these novel targets may result in finding novel compounds efficient for the control of these parasites

Saudi-KAU Coupled Global Climate Model: Description and Performance

n/

Estimating global injuries morbidity and mortality : methods and data used in the Global Burden of Disease 2017 study

Background: While there is a long history of measuring death and disability from injuries, modern research methods must account for the wide spectrum of disability that can occur in an injury, and must provide estimates with sufficient demographic, geographical and temporal detail to be useful for policy makers. The Global Burden of Disease (GBD) 2017 study used methods to provide highly detailed estimates of global injury burden that meet these criteria. Methods: In this study, we report and discuss the methods used in GBD 2017 for injury morbidity and mortality burden estimation. In summary, these methods included estimating cause-specific mortality for every cause of injury, and then estimating incidence for every cause of injury. Non-fatal disability for each cause is then calculated based on the probabilities of suffering from different types of bodily injury experienced. Results: GBD 2017 produced morbidity and mortality estimates for 38 causes of injury. Estimates were produced in terms of incidence, prevalence, years lived with disability, cause-specific mortality, years of life lost and disability-adjusted life-years for a 28-year period for 22 age groups, 195 countries and both sexes. Conclusions: GBD 2017 demonstrated a complex and sophisticated series of analytical steps using the largest known database of morbidity and mortality data on injuries. GBD 2017 results should be used to help inform injury prevention policy making and resource allocation. We also identify important avenues for improving injury burden estimation in the future

Global injury morbidity and mortality from 1990 to 2017 : results from the Global Burden of Disease Study 2017

Correction:Background Past research in population health trends has shown that injuries form a substantial burden of population health loss. Regular updates to injury burden assessments are critical. We report Global Burden of Disease (GBD) 2017 Study estimates on morbidity and mortality for all injuries. Methods We reviewed results for injuries from the GBD 2017 study. GBD 2017 measured injury-specific mortality and years of life lost (YLLs) using the Cause of Death Ensemble model. To measure non-fatal injuries, GBD 2017 modelled injury-specific incidence and converted this to prevalence and years lived with disability (YLDs). YLLs and YLDs were summed to calculate disability-adjusted life years (DALYs). Findings In 1990, there were 4 260 493 (4 085 700 to 4 396 138) injury deaths, which increased to 4 484 722 (4 332 010 to 4 585 554) deaths in 2017, while age-standardised mortality decreased from 1079 (1073 to 1086) to 738 (730 to 745) per 100 000. In 1990, there were 354 064 302 (95% uncertainty interval: 338 174 876 to 371 610 802) new cases of injury globally, which increased to 520 710 288 (493 430 247 to 547 988 635) new cases in 2017. During this time, age-standardised incidence decreased non-significantly from 6824 (6534 to 7147) to 6763 (6412 to 7118) per 100 000. Between 1990 and 2017, age-standardised DALYs decreased from 4947 (4655 to 5233) per 100 000 to 3267 (3058 to 3505). Interpretation Injuries are an important cause of health loss globally, though mortality has declined between 1990 and 2017. Future research in injury burden should focus on prevention in high-burden populations, improving data collection and ensuring access to medical care.Peer reviewe

Estimating global injuries morbidity and mortality : methods and data used in the Global Burden of Disease 2017 study

Background While there is a long history of measuring death and disability from injuries, modern research methods must account for the wide spectrum of disability that can occur in an injury, and must provide estimates with sufficient demographic, geographical and temporal detail to be useful for policy makers. The Global Burden of Disease (GBD) 2017 study used methods to provide highly detailed estimates of global injury burden that meet these criteria. Methods In this study, we report and discuss the methods used in GBD 2017 for injury morbidity and mortality burden estimation. In summary, these methods included estimating cause-specific mortality for every cause of injury, and then estimating incidence for every cause of injury. Non-fatal disability for each cause is then calculated based on the probabilities of suffering from different types of bodily injury experienced. Results GBD 2017 produced morbidity and mortality estimates for 38 causes of injury. Estimates were produced in terms of incidence, prevalence, years lived with disability, cause-specific mortality, years of life lost and disability-adjusted life-years for a 28-year period for 22 age groups, 195 countries and both sexes. Conclusions GBD 2017 demonstrated a complex and sophisticated series of analytical steps using the largest known database of morbidity and mortality data on injuries. GBD 2017 results should be used to help inform injury prevention policy making and resource allocation. We also identify important avenues for improving injury burden estimation in the future.Peer reviewe

Analysis of IgM sub-variants related to ancestral tetraploidy in salmonid fish

Atlantic salmon (Salmo salar) and brown trout (Salmo trutta) possess two paralogous IgM heavy chain (μ) genes related to ancestral tetraploidy. Accordingly, IgM subpopulations of Atlantic salmon and brown trout can be separated by gradient anion exchange chromatography (AEC) into two distinct peaks. In contrast, IgM of arctic char (Salvelinus alpinus) and rainbow trout (Oncorhynchus mykiss) is eluted in a single peak. In the present study mass spectrometry analysis verified that IgM of peak 1 (subpopulation 1) have heavy chains previously designated as μB type whereas IgM of peak 2 (subpopulation 2) have heavy chains of μA type, in Atlantic salmon and brown trout. Salmon IgM of both peak 1 and peak 2 contain light chains of the two most common isotypes: IgL1 and IgL3. Two adjacent cysteine residues are present near the C-terminal part of μB, in contrast to one cysteine residue in μA. Most likely, the additional cysteine is involved in inter-chain disulfide bonding and influences the elution profiles of IgM-A and IgM-B on AEC. Molecular cloning of μ cDNA from arctic char revealed two sub-variants (μA-1 and μA-2), and hybrids of char/salmon expressed μA-1, μA-2, μA and μB, indicating that there are two paralogous μ loci in the haploid genome of char, like in Atlantic salmon. Neither of the μ sub-variants in arctic char have the additional cysteine, and char IgM, as well as salmon and brown trout IgM-A, show a lower degree of inter-chain disulfide bonding than IgM-B when subjected to denaturation and gel electrophoresis under non-reducing conditions. Surprisingly, a monoclonal antibody MAb4C10 against rainbow trout IgM, reacted with μA in salmon, whereas in brown trout it reacted with μB. MAb4C10 was conjugated to magnetic beads and used to separate cells, demonstrating that μ transcripts residing from captured cells were primarily of A type in salmon and B type in brown trout. It is plausible to assume that DNA has been exchanged between the paralogous A and B loci during evolution while maintaining the two sub-variants, with and without the extra cysteine. An analysis of amino acid substitutions in μA and μB of salmon and brown trout indicated that the third constant domain is essential for MAb4C10 binding. This was supported by 3D modeling and was finally verified by studies of MAb4C10 reactivity with a series of recombinant μ3 constructs. Substitution of a proline residue located in the loop between the B and C beta strands of salmon μΑ3 eliminated MAb4C10 reactivity. Accordingly, the reverse substitution in salmon μB restored MAb4C10 reactivity. Molecular cloning of MAb4C10 cDNA and mass spectrometry analysis confirmed that MAb4C10 is of IgG-1 subtype, and the VH sequence of MAb4C10 was determined. To reveal possible differential expression of IgM-A and IgM-B, a broad spectrum of samples from previous and ongoing experiments (fresh water and salt water) and unvaccinated/vaccinated diploid and triploid fish were analyzed. The μA and μB genes appeared to be uniformly expressed in a series of tissues, whereas the AEC profiles of purified IgM from vaccinated fish indicated that the A:B ratio can be skewed in challenged fish

Comparative analysis of IgM sub-variants in salmonid fish and identification of a residue in mu 3 which is essential for MAb4C10 reactivity

In rainbow trout (Onchorhynchus mykiss) it has been shown that high affinity IgM antibodies havea higher degree of disulfide polymerization and a longer half life time. In the present study, distinct IgMsub-variants related to ancestral tetraploidy in salmonidfish were analyzed to reveal possible charac-teristic differences between these. A monoclonal antibody (MAb4C10) which distinguishes between IgM-A and IgM-B in Atlantic salmon (Salmo salar) and brown trout (Salmo trutta) was further characterized. Itwas shown that substitution of a proline located in the loop between the B and C beta strands of the thirdconstant domain (m3) of salmonmA eliminated MAb4C10 reactivity. Accordingly, the reverse substitutionin salmonmB restored MAb4C10 reactivity. Molecular cloning ofmcDNA from arctic char (Salvelinusalpinus) revealed two sub-variants (mA-1 andmA-2), i.e. a similar situation as in Atlantic salmon andbrown trout. However, arctic char IgM eluted in one peak by anion exchange chromatography, in contrastto salmon and brown trout IgM that are eluted in two peaks. The only characteristic residue of salmonand brown troutmB is an additional cysteine in the C-terminal part ofm4. Most likely, this cysteine isinvolved in inter-chain disulfide bonding and influences the elution profiles of IgM-A and IgM-B on anionexchange chromatography. Neither of themsub-variants in arctic char have the additional cysteine, andchar IgM, as well as salmon and brown trout IgM-A, showed a lower degree of inter-chain disulfidebonding than IgM-B when subjected to denaturation and gel electrophoresis under non-reducingconditions. Hybrids of char/salmon expressedmA-1,mA-2,mA andmB, indicating that there are twoparalogous Ig heavy chain gene complexes in the haploid genome of char, like in Atlantic salmon. Acomparison of salmonidmsequences is presented, including representatives ofSalmoninae(trout, salmonand char),Thymallinae(grayling) andCoregoninae(whitefish

Diagnostic approaches and prevalence of Rifampicin resistant Mycobacterium tuberculosis in District Mardan

The disease tuberculosis (TB) caused by Mycobacterium Tuberculosis (MTB) is most common infectious disease in developing countries. The disease is fatal if not treated during the early stages of infection, thereby early and precise detection is a decisive step in curing the disease. The aim of this study was to analyze the prevalence of tuberculosis in patients reporting to Mardan Medical Complex (MMC), located in the district Mardan, KPK, Pakistan. The sputum of patients was analysed by Ziehl-Nilsen (ZN) staining technique followed by light microscopy called Acid-Fast Bacillus (AFB) staining. The sputum samples were collected from the patients and analysed by special PCR method called GeneXpert MTB/RIF assay, for genomic detection and resistance assay for rifampicin antibiotic were used, are the commonly used medicine for the treatment of MTB infection. Total 121 patients reported to MMC, represented 74 % patients from Mardan, 12% from Nowshera and 14% from Swabi. These patients were screened for the aim to evaluate the techniques for the detection of MTB. The light microscopy method confirmed 66 (55%) of the patients positive for MTB, whereas the same samples reported 78 (68%) patients positive for MTB through GeneXpert MTB/RIF assay, The Positive Predictive Value (PPV) and Negative Predictive Value (NPV) found for light microscopy were 99% and 78.1% respectively. The most used drug rifampicin was found ineffective in 9 patients (7%). Additionally, 83% of the patients when interviewed had a folk history of tuberculosis